Lawsuits filed by patients reveal how drugmakers use kickbacks to doctors and wrong information provided by sales reps at the expense of your safety. “Cancer patients only get one shot at first-line treatments,” the lawsuit said, “and defendants took that opportunity away.” The drug was Tarceva (erlotinib), the company was Genentech and the cancer was lung cancer, one of the most deadly kinds. Lung cancer is the most commonly diagnosed cancer in the US (except for non-melanoma skin cancer) and it is by far the deadliest. More women die of lung cancer than the combined deaths due to breast, ovarian and…

Read More